Press Release / Business / Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers, Restraints, Growth 2025
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers, Restraints, Growth 2025
By Minakshi on January 25 2019 | 314 Views
ResearcahMoz presents this most up-to-date research on “Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers, Restraints, Growth Opportunities, and Challenges 2018 to 2025”.
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
Request a Sample PDF Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1932620
In 2017, the global Chemotherapy-Induced Nausea and Vomiting (CINV) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global Chemotherapy-Induced Nausea and Vomiting (CINV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chemotherapy-Induced Nausea and Vomiting (CINV) development in United States, Europe and China. The key players covered in this study Merck Eisai ProStrakan Helsinn Holding Mundipharma Qilu Pharma Teva Novartis Heron Therapeutics Roche Mylan Tesaro Market segment by Type, the product can be split into CINV PONV Market segment by Application, split into Hospitals Ambulatory Surgical Centers Diagnostic Centers
View Complete TOC with Tables and Figures index at: https://www.researchmoz.us/global-chemotherapy-induced-nausea-and-vomiting-cinv-market-size-status-and-forecast-2018-2025-report.html/toc
Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America
About Us
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
tmrresearchblog.com
|
Latest Exclusive Press Release |
|